Valeant Pharmaceuticals International, Inc.

17.77 +0.06(0.34%) Date: Jul 26, 7:54PM EDT

Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to Continue Gaining Over Future Asset Sales

The pharmaceutical company can leverage asset sales to pay off its debt load

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Gains on Potential Debt-for-Equity Swap

The pharmaceutical company’s swap option indicates that its equity is not worth nothing, according to an Evercore ISI analyst

Billionaire John Paulson Gets on Board with Valeant Pharmaceuticals Intl Inc (VRX)

Valeant is likely to focus on core business segments and use proceeds from sale of non-core assets to de-lever itself

Valeant Pharmaceuticals International Inc (NYSE:VRX): Cantor Fitzgerald Initiates Coverage with Overweight

A Cantor Fitzgerald analyst remains optimistic over the pharmaceutical company's solid execution and future growth prospects